On the other hand, Beimdiek et al. demonstrated in their study that there are no significant differences in AGP concentrations between patients with moderately severe and severe COVID-19 (in moderately severe COVID-19, the median value was 150 mg/dL, while in severe COVID-19, the median value was 173.5 mg/dL) [15], and the AGP concentration values we obtained for the group of patients with severe COVID-19 (median: 166.81 mg/dL) are similar to the values reported by the authors. The gene discussed is ATP5MK; the disease is COVID-19.